English | 简体中文 | 繁體中文 | 한국어
 English Press Releases
 Medicine BioTech
B-cell lymphoma clinical trials now open on the TrialWire Platform
Jan 05, 2022 17:10 HKT
Oculis appoints Mr. Webb Ding as Global Chief Operating Officer and General Manager (China)
Jan 05, 2022 15:27 HKT
Apollomics Inc. Announces CEO Guo-Liang Yu, PhD Appointed as Chairman of the Board for the BayHelix Group
Jan 04, 2022 10:10 HKT
Sirnaomics Ltd., RNA Therapeutics Biopharmaceutical Company with Presence in China and US, Lists on Main Board of SEHK
Dec 30, 2021 15:55 HKT
Sirnaomics Ltd. Announces Proposed Listing on the Main Board of SEHK
Dec 19, 2021 20:48 HKT
Pharmaron recognized with 2 Awards at China Securities Golden Bauhinia Awards Ceremony
Dec 17, 2021 17:45 HKT
Acumen Diagnostics granted Ministry of Health COVID-19 offsite PCR testing license, up to 100 sites island-wide
Dec 16, 2021 11:00 HKT
HMI Group Expands Singapore Presence, Doubles Down on Value-based Care Offering
Dec 10, 2021 13:00 HKT
Biolidics to Commence Commercial Production of its ClearEpi SARS-COV-2 Neutralising Antibody Rapid Test Kit
Dec 09, 2021 08:32 HKT
Avantor Provides Critical Personal Protection Supplies to Vulnerable Populations through NGOs
Dec 06, 2021 10:00 HKT
Acumen Diagnostics' PCR capabilities to tackle Omicron COVID-19 variant
Dec 03, 2021 14:00 HKT
SinoMab Announces the Completion of Enrollment in Phase III Clinical Trial in China for its Flagship Product, SM03
Nov 30, 2021 20:50 HKT
Jacobson Pharma Announces FY2022 Interim Results
Nov 26, 2021 19:39 HKT
SinoMab Was Invited to Attend the Inaugural Asia Summit on Global Health
Nov 26, 2021 18:26 HKT
Inaugural Asia Summit on Global Health successfully explores healthcare landscape
Nov 25, 2021 20:00 HKT
Inaugural Asia Summit on Global Health opens today
Nov 24, 2021 18:00 HKT
ACT Genomics and Sanomics Merge to Unleash Hong Kong's Global Potential in Healthcare Technology
Nov 22, 2021 16:57 HKT
Apollomics Inc. Doses First Patient in Phase 3 Clinical Trial with APL-106 (Uproleselan Injection) in Chinese Patients with Relapsed/Refractory Acute Myeloid Leukemia
Nov 22, 2021 10:40 HKT
Aohua Endoscopy, a Leading Endoscope Company Invested by Legend Capital, Successfully Listed on China's STAR Market
Nov 15, 2021 17:15 HKT
Olympus Launches Venture Capital Fund to Strengthen Medtech Leadership
Nov 12, 2021 07:30 HKT
<< Previous  Next >>
Copyright © 2025 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 214 890 4418 | Beijing: +86 400 879 3881 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575

Connect With us: